Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

Autor: Keitel, Wendy A., Jackson, Lisa A., Edupuganti, Srilatha, Winokur, Patricia L., Mulligan, Mark J., Thornburg, Natalie J., Patel, Shital M., Rouphael, Nadine G., Lai, Lilin, Bangaru, Sandhya, McNeal, Monica M., Bellamy, Abbie R., Hill, Heather R., Bond, Nanette, Bosworth, Kathy, Brown, Janet, Banay, Jess, Cheesman, Coni, Lanford, Tracey, Munoz, Flor, Wells, Janet, Carste, Barb, Dunstan, Maya, Mathis, Angel, Parikh, Mihir, Phillips, C. Hallie, Spingola, Alyssa, Starkovich, Pat, Suyehira, Janice, Beck, Allison, Mask, Karen, Bower, Mary, Osinski, Eileen, Rimann, Nayoka, Turner, Pamela, Wang, DongLi, Stapleton, Jack, Won, Regina, Wagner, Nancy, Dull, Geraldine, Gerot, Necole, Reidy, Mary, Zhao, Dan, Segar, Ellen, Slaughter, James C., McDonough, Megan, He, Fenhua, Salata, Robert, Meissner, Cody, Sheffield, Jeanne, Spigarelli, Michael, Greenberg, Stephen, Agrawal, Anoop, Dublin, Sascha, Arterburn, David, Rimland, David, Ribner, Bruce, Meier, Jeff, Buchanan, Wendy, Chang, Soju, Lambert, Linda, Murray, Suzanne, Riddle, Valerie, Spiro, David

Background Variant influenza A(H3N2) viruses (H3N2v) have transmitted recently from pigs to humans in the United States. Vaccines strategies are needed. Methods Healthy adults received 2 doses of subvirion H3N2v vaccine (15 µg of hemagglutinin/dose)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8065d14fa42dc4115292dd108cbe4a43
https://europepmc.org/articles/PMC4539893/